GTHRX Mutual Fund

GTHRX Mutual Fund

NAV$41.97
See how much of GTHRX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Mar 31, 2026

Net Assets
-
Expense Ratio
1.32%
Dividend Yield (Current)
5.59%
Holdings
81
Inception Date
Sep 30, 2025
Fund Family
Invesco (US)
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+1.49%
1 Year+16.85%
3 Year+7.26%
5 Year+2.16%
10 Year+6.73%

Asset Allocation

Stocks: 95.79%
Cash: 4.21%
See how much of GTHRX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report is $25, once. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
LLYEli Lilly & Co.9.07%
JNJJohnson & Johnson - Common5.81%
AZN:LNAstraZeneca PLC4.34%
GILDGilead Sciences4.10%
ABBVAbbvie Inc.3.67%
Top 10 Concentration: 42.62%Report Date: Mar 31, 2026
Download all 81 holdings for GTHRX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
5.59%
Frequency
Annually

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

GTHRX Mutual Fund Overview

GTHRX Mutual Fund (Invesco Health Care Fund Class R) is managed by Invesco (US). GTHRX expense ratio is 1.32%, holding 81 positions across sectors including Health Care, Real Estate. Inception date: 2025-09-30.

GTHRX performance shows a YTD return of 1.49%. The 1-year return is 16.85% and the 5-year return is 2.16%. GTHRX dividend yield stands at 5.59%, paid annually.

GTHRX top holdings include Eli Lilly & Co. (9.1%), Johnson & Johnson - Common (5.8%), AstraZeneca PLC (4.3%), Gilead Sciences (4.1%), Abbvie Inc. (3.7%). Go to all GTHRX holdings, GTHRX sectors, or GTHRX dividends.

GTHRX can be compared against other funds. Use GTHRX overlap to find shared positions, or GTHRX vs another fund for a side-by-side view. GTHRX alternatives are available via the screener, along with tax-loss harvesting opportunities.